ClinicalTrials.Veeva

Menu

Cerebellar Non-invasive Stimulation in Ataxias

U

University of Sao Paulo General Hospital

Status

Unknown

Conditions

Cerebellar Ataxia

Treatments

Device: Transcranial Magnetic Stimulation (TMS)
Device: Sham Stimulation

Study type

Interventional

Funder types

Other

Identifiers

NCT03213106
1.310.275

Details and patient eligibility

About

Cerebellar ataxias are a group of disorders caused by cerebellar affections, for which currently no specific treatment is available. Some limited studies verified the effects of cerebellar transcranial magnetic stimulation (TMS) on ataxic symptoms, with good results. So far it is not known which patients could benefit. Our hypothesis is that cerebellar TMS could improve ataxic symptoms in some patients.

Full description

Thirty patients with cerebellar ataxia will be included in our protocol. Ataxia might be due to several aetiologies, from degenerative to genetic and vascular diseases. Patients will be submitted to a neuronavigation protocol for the precise location of the dentate nucleus contralateral to the most symptomatic side. After that, participants will be randomly assigned to 5 active or 5 placebo sessions of 1Hz TMS over the located area. After the first 5 sessions and a period of at least 4 weeks washout, patients will cross over and receive other 5 sessions, active or sham. Clinical and video evaluations will be conducted before and after active and sham cluster of sessions.

Enrollment

30 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • identification of cerebellar ataxia based on neurologic examination
  • no improvement after rehabilitation
  • symptoms onset of at least 6 months

Exclusion criteria

  • Younger than 18 months
  • Pregnant or breastfeeding women
  • Participation in other clinical trials
  • Epilepsy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Quadruple Blind

30 participants in 2 patient groups

Transcranial Magnetic Stimulation (TMS) Stimulation
Experimental group
Description:
All patients will receive 5 sessions of active TMS stimulation.
Treatment:
Device: Transcranial Magnetic Stimulation (TMS)
Sham Stimulation
Sham Comparator group
Description:
All patients will receive 5 sessions of active TMS stimulation
Treatment:
Device: Sham Stimulation

Trial contacts and locations

1

Loading...

Central trial contact

Carina C França, MD; Rubens G Cury, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems